InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
CEODisclosed buys
0
Disclosed sells
0
T+90 hit rate
22%
T+90 mean return
-20.4%
Across 9 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the detailed record of transactions filed by Kramer Robert, Chief Executive Officer. Director active across 1 company, notably Emergent BioSolutions Inc.. In total, 10 filings have been recorded. Activity tracked since 8 May 2021. The latest transaction was disclosed on 9 June 2023 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations10 total
70,769 shares0Common StockSEC:0001367644-23-000119:0
19,231 shares0Common StockSEC:0001367644-23-000071:0
3,226 shares@ US$12.3831.5% of flowCommon StockSEC:0001367644-23-000055:0
1,428 shares@ US$14.3016.1% of flowCommon StockSEC:0001367644-23-000032:0
278 shares0Common StockSEC:0001367644-23-000017:0
33,833 shares0Common StockSEC:0001367644-22-000044:0
1,419 shares@ US$42.230.013% mcap84.6% of flowCommon StockSEC:0001367644-22-000031:0
4,264 shares0Common StockSEC:0001367644-22-000022:0
94 shares@ US$61.627.7% of flowCommon StockSEC:0001367644-21-000077
94 shares@ US$61.620.0012% mcap7.7% of flowCommon StockSEC:0001367644-21-000077:0
10 of 10 declarations
About Kramer Robert
Robert Kramer is the President and CEO of Emergent BioSolutions Inc. He is responsible for the strategic direction and overall management of the company.
